Latest California Healthline Stories
GOP Seeks To Sweeten Health Savings Account Deals. Will Consumers Bite?
A new study found that fewer than half of people with health savings accounts deposited any money in them in 2016.
Messages From Beyond: Using Technology To Seal Your Legacy
From slick videos to digital “time capsules,” folks have new ways to “stay alive” long after they die.
Medicare’s Financial Outlook Slightly Improved, Trustees Say
The assessment pushes back the date for the hospital insurance trust fund to go bankrupt by one year. It also says Part B premiums next year will be stable.
Senate Health Bill Still Short On ‘Yays’ But Leaders Vow Vote Next Week
At least two Republicans have already said they cannot support the new legislative draft, which means all other GOP senators would have to agree to the bill to pass it.
Transgender Health Care Targeted In Crusade To Undo ACA
HHS Secretary Tom Price and President Donald Trump have vowed to use administrative powers to mitigate the health law rules that created “burdens” or that don’t match up with their agenda.
Senate Revises Health Care Legislation: Read The New Bill
The Senate releases an updated draft of its health care legislation. Read the bill and compare with the original.
California Sued For Allegedly Substandard Medi-Cal Care
The lawsuit is a civil rights case on behalf of Latinos, who comprise nearly half of the program’s enrollees. But the advocates who filed it also hope to get class action certification for all Medi-Cal enrollees.
DNA Links Deadly Germs, Tainted Heart Surgery Devices To German Factory
LivaNova plant in Germany is the likely source behind outbreak that has sickened more than 100 people since 2013.
One Force Lacking In Fight Against Opioid Addiction In Rural California: Doctors
Many physicians lack the inclination and training to prescribe medications to assist in treatment. State officials hope a $90 million federal grant will help change this.
Whichever Way ‘Repeal and Replace’ Blows, Pharma Is Due For Windfall
A little-noticed provision in President Donald Trump’s executive order on drug prices may offer a clue to why Big Pharma hasn’t opposed a bill that could bleed their balance sheets of millions of patients.